Alkindi
Payments companies reported to CMS as associated with Alkindi. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Alkindi, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Alkindi
These are the largest totals companies reported as associated with Alkindi. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Kanika Ghai | Park Ridge, IL | Pediatric Endocrinology | $138,759.00 |
| Mitchell Geffner | Los Angeles, CA | Pediatric Endocrinology | $21,014.00 |
| Philippe Backeljauw | Cincinnati, OH | Pediatric Endocrinology | $18,155.14 |
| Mabel Yau | New York, NY | Pediatric Endocrinology | $12,454.91 |
| Quentin Vanmeter | Atlanta, GA | Pediatric Endocrinology | $11,086.13 |
| Jadranka Popovic | Pittsburgh, PA | Pediatric Endocrinology | $7,196.09 |
| Bradley Miller | Minneapolis, MN | Pediatric Endocrinology | $4,823.96 |
| Leslie Pitts | Keene, NH | Family Medicine | $3,500.00 |
| Courtney Finlayson | Chicago, IL | Pediatric Endocrinology | $3,175.83 |
| Susan Nunez | Austin, TX | Pediatric Endocrinology | $2,925.76 |
Prescribed Alkindi?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.